SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-14-167242
Filing Date
2014-04-29
Accepted
2014-04-29 16:20:36
Documents
10
Period of Report
2014-06-19
Effectiveness Date
2014-04-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A d695813ddef14a.htm DEF 14A 432747
2 GRAPHIC g695813g32j52.jpg GRAPHIC 8436
3 GRAPHIC g695813g48m71.jpg GRAPHIC 1867
4 GRAPHIC g695813g53o79.jpg GRAPHIC 9280
5 GRAPHIC g695813g54c85.jpg GRAPHIC 1889
6 GRAPHIC g695813g70y24.jpg GRAPHIC 1873
7 GRAPHIC g695813g72r89.jpg GRAPHIC 1873
8 GRAPHIC g695813g93j03.jpg GRAPHIC 2435
9 GRAPHIC g695813pca_pg01.jpg GRAPHIC 2033
10 GRAPHIC g695813pca_pg02.jpg GRAPHIC 2044
  Complete submission text file 0001193125-14-167242.txt   478845
Mailing Address 1901 OLATHE BOULEVARD KANSAS CITY KS 66103
Business Address 1901 OLATHE BOULEVARD KANSAS CITY KS 66103 913.951.2130
ARATANA THERAPEUTICS, INC. (Filer) CIK: 0001509190 (see all company filings)

IRS No.: 383826477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35952 | Film No.: 14794178
SIC: 2834 Pharmaceutical Preparations